Brookfield Corporation
BAM
$52.84
+0.67%
Brookfield Asset Management Ltd. is a global alternative asset manager, overseeing $1.181 trillion in total managed assets, including $602.7 billion in fee-earning AUM, across credit, private equity, and real assets. As one of the world's largest alternative managers, it is a market leader with a diversified platform serving institutional investors (90% of AUM) and high-net-worth individuals, and is 73% owned by Brookfield Corporation. The current investor narrative centers on the firm's strategic expansion into data center power solutions, highlighted by a $25 billion partnership with Bloom Energy, while also navigating a period of significant stock price volatility and a recent recovery from 52-week lows.…
BAM
Brookfield Corporation
$52.84
Related headlines
Investment Opinion: Should I buy BAM Today?
Based on the analysis, BAM is rated a Hold. The consensus recommendation is 'Buy' with an average target price of $56.30, implying a 5.9% upside, which is modest. The stock offers strong growth and profitability, but the valuation is stretched, and dividend coverage is a concern. The thesis is that BAM is a high-quality asset manager with solid fundamentals, but the current price already reflects much of the optimism.
Sign up to view all
BAM 12-Month Price Forecast
The AI assessment is neutral with medium confidence. BAM's strong fundamentals are offset by valuation and dividend concerns. The stock is likely to trade in a range, with upside potential if growth accelerates, but downside risk if market conditions worsen. Key factors to watch include revenue growth sustainability, dividend coverage, and market sentiment. An upgrade to bullish would require evidence of sustained growth above 20% and improved dividend coverage, while a downgrade to bearish would occur if growth decelerates or the dividend is cut.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Brookfield Corporation's 12-month outlook, with a consensus price target around $57.19 and implied upside of +8.2% versus the current price.
Average Target
$57.19
0 analysts
Implied Upside
+8.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$44 - $70
Analyst target range
Analyst coverage is substantial with 18 analysts, and the consensus recommendation is 'Buy' with a mean rating of 2.28 (where 1 is Strong Buy and 5 is Sell). The average target price is $56.30, implying a 5.9% upside from the current price of $53.17. The distribution includes 10 Buy ratings, 6 Hold, and 2 Sell, indicating a moderately bullish sentiment. The target range spans from $44.00 (low) to $70.00 (high), with the high target suggesting a 31.7% upside, likely assuming continued AUM growth and successful capital deployment. The low target implies a 17.2% downside, possibly reflecting risks from market volatility or underperformance. Recent ratings actions have been stable, with no major upgrades or downgrades in the last three months, but the presence of a wide target spread indicates uncertainty about the pace of growth and market conditions.
Bulls vs Bears: BAM Investment Factors
BAM presents a mixed picture: strong revenue growth and profitability are offset by a high valuation and dividend coverage concerns. The bull case is supported by accelerating revenue, exceptional margins, and a solid balance sheet, while the bear case highlights valuation risk, underperformance, and payout issues. Currently, the bull case has slightly stronger evidence due to robust fundamentals and strategic growth initiatives, but the stock's premium valuation and high beta introduce significant risk. The key tension is whether BAM can sustain its growth trajectory to justify its valuation, or if market conditions will compress multiples, leading to further downside.
Bullish
- Strong Revenue Growth: Q1 2026 revenue grew 22.06% YoY to $1.319 billion, with a clear upward trajectory from $1.09 billion in Q2 2025. This accelerating growth reflects strong fundraising and fee income, supporting the investment case.
- Exceptional Profitability: Net margin is 46.1% and gross margin expanded to 82.3% in Q1 2026, up from 73.2% in Q4 2025. The asset-light fee-based model drives high operating leverage and ROE of 27.9%.
- Solid Balance Sheet: Debt-to-equity is 0.41 and current ratio is 4.20, indicating ample liquidity and low financial risk. Free cash flow TTM is $2.315 billion, providing flexibility for dividends and growth investments.
- Attractive Valuation vs History: Current PE of 34.02x is below the 5-year average of ~37x, and PS ratio of 13.35x is well below the historical average of 50x. This suggests the stock is trading at a discount to its own valuation history.
Bearish
- High Valuation Premium: PE of 34.02x and PS of 13.35x are expensive relative to industry averages (not provided), and PEG of 2.15x indicates the stock is overvalued relative to its growth rate. This leaves little margin for error.
- Dividend Not Fully Covered: Payout ratio of 113.4% means dividends exceed earnings, which could pressure cash flow or force dividend cuts if earnings falter. This is a red flag for income investors.
- Significant Underperformance: 1-year price change is -15.51% and relative strength vs S&P 500 is -36.97%, indicating persistent underperformance. This suggests negative sentiment and potential headwinds.
- High Beta and Volatility: Beta of 1.254 implies higher sensitivity to market swings, and the stock has a max drawdown of -32.16% in the past year. This makes it a risky holding during market downturns.
BAM Technical Analysis
The stock is in a recovery phase after a prolonged downtrend, with the 1-year price change at -15.51% and a 52-week range of $42.20 to $63.54. Currently trading at $53.17, the stock is at 83.4% of its 52-week range, indicating a strong rebound from the lows but still below the highs. This positioning suggests improving momentum, though the stock remains below its 52-week high, reflecting lingering bearish sentiment from the past year. The 1-year relative strength versus the S&P 500 is -36.97%, showing significant underperformance, but the recent price action is attempting to reverse that trend.
Beta
1.25
1.25x market volatility
Max Drawdown
-32.2%
Largest decline past year
52-Week Range
$42-$63
Price range past year
Annual Return
-13.7%
Cumulative gain past year
| Period | BAM Return | S&P 500 |
|---|---|---|
| 1m | +13.1% | +2.4% |
| 3m | +8.4% | +4.7% |
| 6m | +0.9% | +11.7% |
| 1y | -13.7% | +21.3% |
| ytd | -1.1% | +13.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BAM Fundamental Analysis
Revenue growth has been robust, with Q1 2026 revenue of $1.319 billion, up 22.06% year-over-year, and a clear upward trajectory from $1.09 billion in Q2 2025 to $1.236 billion in Q4 2025. The growth is driven by management fees and incentive fees, with management service revenue at $860 million and incentive fees at $130 million in the latest quarter. This accelerating growth indicates strong demand for alternative assets and successful fundraising, supporting the investment case. Profitability is exceptional, with Q1 2026 net income of $608.5 million and a net margin of 46.1%, while gross margin expanded to 82.3% from 73.2% in Q4 2025. Operating margin is also high at 65.8%, reflecting the asset-light, fee-based business model. The balance sheet is solid with a debt-to-equity ratio of 0.41 and a current ratio of 4.20, indicating ample liquidity. Free cash flow for the trailing twelve months is $2.315 billion, and the company generated $339 million in operating cash flow in Q1 2026, despite significant dividend payments of $809 million. ROE is strong at 27.9%, and the payout ratio of 113.4% suggests dividends are not fully covered by earnings, but the company's cash generation supports its capital return program.
Quarterly Revenue
$1.3B
2026-03
Revenue YoY Growth
+22.1%
YoY Comparison
Gross Margin
82.3%
Latest Quarter
Free Cash Flow
$2.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BAM Overvalued?
Given positive net income, the PE ratio is the primary valuation metric. The trailing PE is 34.02x, while the forward PE is 24.55x, indicating the market expects significant earnings growth. The gap between trailing and forward PE implies a 27.8% expected earnings increase, reflecting optimism about future fee-related earnings. Compared to the industry average (not provided), the stock trades at a premium, with a PS ratio of 13.35x and a PB ratio of 6.91x, suggesting investors are paying a high price for its growth and profitability. The PEG ratio of 2.15x indicates that the stock is expensive relative to its growth rate, but the high net margin and ROE justify some premium. Historically, the current PE of 34.02x is below the 5-year average of around 37x, and the PS ratio of 13.35x is well below the historical average of 50x, suggesting the stock is trading at a discount to its own valuation history, potentially offering value if growth persists.
PE
34.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 4x~44x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
19.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks include a high payout ratio of 113.4%, indicating dividends are not fully covered by earnings, which could lead to dividend cuts if cash flow weakens. The company's debt-to-equity of 0.41 is manageable, but the reliance on fee income makes it sensitive to market cycles and AUM fluctuations. Revenue growth is strong but concentrated in alternative assets, which are cyclical and subject to investor sentiment shifts. Free cash flow of $2.315 billion TTM provides a cushion, but the high payout ratio reduces retained capital for growth.
FAQ
The key risks include: 1) Financial risk from a high payout ratio of 113.4%, which could lead to dividend cuts; 2) Market risk from high beta of 1.254, making the stock sensitive to market swings; 3) Competitive risk from other asset managers like Blackstone; 4) Company-specific risk from reliance on fee income, which is cyclical. The most severe risk is a market downturn that reduces AUM and fee income, potentially leading to a -20% loss.
The 12-month forecast is mixed: the bull case (30% probability) targets $60-$70, the base case (50% probability) targets $53-$58, and the bear case (20% probability) targets $42-$45. The most likely scenario is the base case, with a target of $56.30, assuming moderate growth and stable market conditions. The key assumption is that revenue growth continues at 15-20% and the dividend is maintained.
BAM is trading at a premium to its historical averages, with a PE of 34.02x versus the 5-year average of ~37x, and a PS of 13.35x versus the historical average of 50x. This suggests the stock is undervalued relative to its own history, but overvalued compared to the broader market. The forward PE of 24.55x implies the market expects significant earnings growth, which may be optimistic. Overall, the stock is fairly valued given its growth prospects, but not a bargain.
BAM is a good buy for investors with a long-term horizon and tolerance for volatility. The stock offers a 5.9% upside to the average analyst target of $56.30, but the valuation is rich at 34x trailing earnings. The biggest downside risk is a dividend cut due to a 113.4% payout ratio, which could pressure the stock. For growth-oriented investors, the strong revenue growth and strategic initiatives make it attractive, but value investors may find better opportunities elsewhere.
BAM is more suitable for long-term investment due to its growth stage and volatility. The stock has a beta of 1.254, indicating higher short-term volatility, but its strong fundamentals and strategic initiatives support long-term growth. The dividend yield of 4.58% provides income, but the high payout ratio is a concern. A minimum holding period of 3-5 years is recommended to ride out market cycles and benefit from AUM growth.